All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.

  TRANSLATE

The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The SOT Hub is an independent medical education platform, supported through a founding grant from Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Ex vivo heart perfusion for DCD heart transplantation with a prolonged AP

By Nathan Fisher

Share:

Mar 18, 2026

Learning objective: After reading this article, learners will be able to cite a new clinical development in heart transplantation.


Results from an analysis of the United Network for Organ Sharing (UNOS) registry, evaluating ex vivo heart perfusion (EVHP) vs static cold storage (non-EVHP) in adult donation after circulatory death (DCD) heart transplantation, stratified by agonal period (AP) duration (N = 1,682; EVHP, n = 1,175; non-EVHP, n = 507), were published in The Journal of Heart and Lung Transplantation by Berg et al. The primary outcome was 1‑year all-cause mortality.

Key data: In multivariable analysis, non-EVHP transplants with a prolonged AP (≥30 min) had a higher risk of 1‑year mortality vs the reference group (non-EVHP + AP <30 min; hazard ratio, 2.17; p = 0.037), whereas EVHP transplants showed no increased mortality risk vs the reference group, regardless of AP duration. In propensity score-matched analysis (n = 120 per group), 1‑year survival was higher with EVHP vs non-EVHP when AP was ≥30 min (p = 0.03). Among transplants with prolonged AP, EVHP grafts had lower odds of acute rejection before discharge vs non-EVHP grafts (adjusted odds ratio, 0.39; 95% confidence interval, 0.16–0.94; p = 0.04).

Key learning: In DCD heart transplantation with a prolonged AP, EVHP may function as an early protective strategy to mitigate the survival disadvantage and increased rejection risk previously reported with prolonged agonal times.

References

Please indicate your level of agreement with the following statements:

The content was clear and easy to understand

The content addressed the learning objectives

The content was relevant to my practice

I will change my clinical practice as a result of this content